← Eichor
Study identifier: NCT06160232 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder

Condition: Severe Alcohol Use Disorder  ·  Sponsor: Brugmann University Hospital

PhasePhase 2
Planned participants62
Who can joinAll sexes, 21 Years to 64 Years
Healthy volunteersNo

About this study

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial

This description comes directly from the study's public registry record.

Talk to the study team

Laetitia Vanderijst, M.Sc.  ·  02 477 22 33  ·  laetitia.vanderijst@ulb.be

Always discuss trial participation with your own doctor first.

Locations (1)

Brugmann University HospitalBrussels, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06160232